1. New oral drug curbs MS disease activity
(Radiology News/Radiology Articles)

... consequences were not apparent until after final-stage clinical studies had begun. Thus, it is imperative to continue to establish the safety of laquinimod. Lancet, June 21, 2008.    ...

2. New oral drug curbs MS disease activity
(Radiology News/Radiology Articles)

Tags: [multiple sclerosis, MS, laquinimod, immune-modulating, brain MRI scans, immune-modulating drug, heart attacks, severe inflammation, final-stage clinical studies]  ...